EW
EW
US28176E1082
Edwards Lifesciences Corporatio
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 6.067.600.000 5.439.500.000
11.5%
Cost of Revenue 1.334.200.000 1.117.500.000
19.4%
Gross Profit 4.733.400.000 4.322.000.000
9.5%
3.097.200.000 2.841.900.000
9.0%
Operating Income 1.636.200.000 1.480.100.000
10.5%
Pretax Income 1.272.900.000 1.548.100.000
17.8%
Net Income Common Stockholders 1.073.500.000 4.174.600.000
74.3%
-- --
--
-- --
--
ende